NASDAQ:AFFX Affymetrix (AFFX) Stock Price, News & Analysis → Are you prepared for a Chinese 'invasion?' (From Behind the Markets) (Ad) Free AFFX Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$14.01▼$14.0150-Day Range N/A52-Week Range$8.28▼$16.15VolumeN/AAverage Volume3.49 million shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Affymetrix alerts: Email Address Ad Behind the MarketsProtect Your Bank Account from ChinaChina is set to launch a gold-backed currency that could shake the financial world. This move will give them unprecedented power over global finance. And could divert trillions from U.S. Treasury bonds.Discover these 4 simple steps here >>> About Affymetrix Stock (NASDAQ:AFFX)Affymetrix, Inc. (Affymetrix) is a provider of life science products and molecular diagnostic products that enable parallel analysis of biological systems at the gene, protein and cell level. The Company operates through two business segments: Affymetrix Core and eBioscience. The Affymetrix Core segment focuses on the development, manufacture and commercialization of systems for genetic analysis in the life sciences, agricultural biotechnology (AgBio) and diagnostic industry. The eBioscience segment primarily focuses on the development, manufacture, marketing and distribution of research products in the areas of flow cytometry, immunoassays, microscopic imaging and other protein-based analyses. The Company sells its products to genomic research centers, academic institutions, government and private laboratories, as well as pharmaceutical, diagnostic and biotechnology companies. It maintains sales and distribution operations across the United States, Europe, Latin America and Asia.Read More Ad Behind the MarketsProtect Your Bank Account from ChinaChina is set to launch a gold-backed currency that could shake the financial world. This move will give them unprecedented power over global finance. And could divert trillions from U.S. Treasury bonds.Discover these 4 simple steps here >>> AFFX Stock News HeadlinesApril 4, 2023 | thestreet.comAffymetrix Reaches New 52-Week High (AFFX)February 21, 2023 | thestreet.comThermo Fisher Can Afford More Deals After Affymetrix BuyJune 18, 2024 | Behind the Markets (Ad)Are you prepared for a Chinese "invasion?"Recently declassified documents show that while the U.S has been distracted in the Middle East... China had been studying our every move... And preparing themselves for not only an armed conflict with the United StatesJanuary 2, 2023 | thestreet.comAffymetrix (AFFX) Stock Drops After Rejecting Origin Technologies Takeover BidMarch 1, 2022 | thestreet.com'Mad Money' Lightning Round: A Group to AvoidJanuary 20, 2022 | thestreet.comThermos Fisher (TMO) Stock Closed Up on Affymetrix AcquisitionSee More Headlines Receive AFFX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Affymetrix and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/17/2016Today6/18/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorN/A Industry N/A Sub-IndustryLife Sciences Tools & Services Current SymbolNASDAQ:AFFX CUSIP00826T10 CIK913077 Webwww.affymetrix.com Phone+1-408-7315000FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report Key CompetitorsThermo Fisher ScientificNYSE:TMOAgilent TechnologiesNYSE:AMettler-Toledo InternationalNYSE:MTDIlluminaNASDAQ:ILMNWatersNYSE:WATView All Competitors AFFX Stock Analysis - Frequently Asked Questions How were Affymetrix's earnings last quarter? Affymetrix Inc (NASDAQ:AFFX) announced its quarterly earnings results on Wednesday, February, 17th. The scientific and technical instruments company reported $0.09 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.11 by $0.02. The scientific and technical instruments company had revenue of $95.60 million for the quarter, compared to analysts' expectations of $93.29 million. During the same quarter in the previous year, the business earned $0.09 earnings per share. What other stocks do shareholders of Affymetrix own? Based on aggregate information from My MarketBeat watchlists, some companies that other Affymetrix investors own include Orchid Island Capital (ORC), XOMA (xoma), Alnylam Pharmaceuticals (ALNY), Ascent Solar Technologies (ASTI), NXP Semiconductors (NXPI), ACADIA Pharmaceuticals (ACAD), Hugoton Royalty Trust (HGT), Intel (INTC), NVIDIA (NVDA) and Applied Materials (AMAT). This page (NASDAQ:AFFX) was last updated on 6/18/2024 by MarketBeat.com Staff From Our PartnersAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredBiden to Launch “FedNOW” [Move Your Money Now]Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentia...Priority Gold | SponsoredBigger Than NVIDIA?With NVIDIA flying high, everyone is looking for the next breakout stock. But right now... There's only ...Behind the Markets | SponsoredBeta testers blew this thing upThis AI trading tool is probably unlike anything you've ever seen before… It scans the entire market and fi...Prosper Trading Academy | SponsoredRadical change coming — do this NOW to protect yourselfI recently uncovered a way the government could use the next crisis as a pretext to gain more control … and ra...Weiss Ratings | SponsoredThe attacks will come for me after releasing this…America’s “Internal Enemies” Exposed New documentary exposes a hidden election plan in Washington D.C. that...Porter & Company | SponsoredThe #1 Crypto That You Don’t Own… YetThere’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay a...Crypto 101 Media | SponsoredBiden Nomination CANCELED?And I believe when they do take the oath of office, their fingers will be crossed… and America will descend in...The Freeport Society | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Affymetrix Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Affymetrix With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.